B
Bas A.J.M. de Mol
Researcher at University of Amsterdam
Publications - 211
Citations - 6869
Bas A.J.M. de Mol is an academic researcher from University of Amsterdam. The author has contributed to research in topics: Aortic valve & Aortic valve replacement. The author has an hindex of 43, co-authored 211 publications receiving 5915 citations. Previous affiliations of Bas A.J.M. de Mol include Eindhoven University of Technology & Sharp Memorial Hospital.
Papers
More filters
Journal ArticleDOI
Percutaneous Mechanical Circulatory Support Versus Intra-Aortic Balloon Pump in Cardiogenic Shock After Acute Myocardial Infarction
Dagmar M. Ouweneel,Erlend Eriksen,Krischan D. Sjauw,Ivo M. van Dongen,Alexander Hirsch,Erik J S Packer,Marije M. Vis,Joanna J. Wykrzykowska,Karel T. Koch,Jan Baan,Robbert J. de Winter,Jan J. Piek,Wim K. Lagrand,Bas A.J.M. de Mol,Jan G.P. Tijssen,José P.S. Henriques +15 more
TL;DR: In this explorative randomized controlled trial involving mechanically ventilated patients with CS after AMI, routine treatment with pMCS was not associated with reduced 30-day mortality compared with IABP.
Journal ArticleDOI
Extracorporeal life support during cardiac arrest and cardiogenic shock: a systematic review and meta-analysis
Dagmar M. Ouweneel,Jasper V. Schotborgh,Jacqueline Limpens,Krischan D. Sjauw,Annemarie E. Engström,Wim K. Lagrand,Thomas G. V. Cherpanath,Antoine H.G. Driessen,Bas A.J.M. de Mol,José P.S. Henriques +9 more
TL;DR: In cardiac arrest, the use of ECLS was associated with an increased survival rate as well as an increase in favourable neurological outcome and in the setting of cardiogenic shock there was a increased survival with ECLs compared with IABP.
Journal ArticleDOI
Prevention of Nosocomial Infection in Cardiac Surgery by Decontamination of the Nasopharynx and Oropharynx With Chlorhexidine Gluconate: A Randomized Controlled Trial
TL;DR: Decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate appears to be an effective method to reduce nosocomial infection after cardiac surgery.
Journal ArticleDOI
Noninvasive continuous arterial blood pressure monitoring with Nexfin
Jerson R. Martina,Berend E. Westerhof,Jeroen van Goudoever,Edouard M. de Beaumont,Jasper Truijen,Yu-Sok Kim,Rogier V. Immink,Dorothea A Jöbsis,Markus W. Hollmann,Jaap R. Lahpor,Bas A.J.M. de Mol,Johannes J. van Lieshout +11 more
TL;DR: Arterial blood pressure can be measured noninvasively and continuously using physiologic pressure reconstruction and values are comparable to invasive monitoring.
Journal ArticleDOI
Safety and feasibility of elective high-risk percutaneous coronary intervention procedures with left ventricular support of the Impella Recover LP 2.5.
José P.S. Henriques,Maurice Remmelink,Jan Baan,René J. van der Schaaf,Marije M. Vis,Karel T. Koch,Evert W. Scholten,Bas A.J.M. de Mol,Jan G.P. Tijssen,Jan J. Piek,Robbert J. de Winter +10 more
TL;DR: There were no important device-related adverse events during LV support with the percutaneous implantable Impella Recover LP 2.5 system, and these encouraging findings must be confirmed by larger studies, longer assist times, and in other patient categories.